| Serial Number | 78178624 |
| Word Mark | P |
| Filing Date | Friday, October 25, 2002 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, October 4, 2013 |
| Registration Number | 3212165 |
| Registration Date | Tuesday, February 27, 2007 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 27, 2005 |
| Certificate of Correction for Registration | In the statement, Column 1, Line 14, "peptide sand polypeptide" is deleted, and, peptides and polypeptides is inserted. In the statement, Column 1, Line 27, "conformations" is deleted, and bioinformatics is inserted. In the statement, Column 1, Line 44, "protonic" is deleted, and, proteomic is inserted. |
| Description of Mark | The mark consists of a stylized letter P in the color purple inside a square outlined in the color purple. |
| Goods and Services | Chemicals for use in the manufacture of pharmaceuticals, cosmetics, and healthcare products; chemicals for use in science, namely, reagents for scientific research; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, therapeutic proteins and biologics for scientific use in drug discovery; peptide sand polypeptide and small molecules for use in scientific research; all of the aforesaid for use in assays, screens and diagnosis |
| Goods and Services | Pharmaceutical preparations for therapeutic, prophylactic and or pharmacological purposes, namely, for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy, ear, nose, throat disease, endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder, genitourinary disease, growth disorder, hematological disease, immune disorder, immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological, mental and cognitive disorder, nutritional disorder, ocular disease, pain, pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder, somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility; pharmaceutical preparations comprised of peptides and polypeptides for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy,ear, nose, throat disease, endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder, genitourinary disease, growth disorder, hematological disease, immune disorder, immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological, mental and cognitive disorder, nutritional disorder, ocular disease, pain, pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder, somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer, uterine motility; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, vaccines |
| Goods and Services | Computer hardware; data processors; computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; computer software for the design and identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; computer software comprised of algorithms for use in analysis and data-mining of sequence chemical databases |
| Goods and Services | Providing temporary use of online non-downloadable computer software for use in the design or identification and characterization of genes and proteins through bioinformatics related techniques; providing temporary use of online non-downloadable software for the design or identification of chemical entities for drug discovery research; providing temporary use of online non-downloadable computer software for use in gene therapy and disease diagnosis; providing temporary use of online non-downloadable computer software comprised of algorithms for use in analysis and data-mining of sequence and chemical databases; providing databases and online databases featuring complementary peptide sequences to all known genes in the human, bacterial, viral, animal and plant genomes; proteomic, genomic, bioinformatics, chemical and scientific consultation services, namely, providing advice and consultation in the fields of genomics, informatics, study of protein properties molecular design; medical, scientific and biotechnological research, namely, identification and characterization of genes and proteins and the design or identification of chemical entities through bioinformatics and related techniques, and providing consultancy and advisory services relating thereto; consultancy, advice and provision of information relating to drug discovery research, disease diagnosis; design, creation and provision of databases, namely, databases for the identification and characterization of genes, proteins and small molecules; design and creation of computer software for data-mining; design, creation and development of proprietary informatics technology, namely for the location and definition of peptide and small molecule ligands; use of bioinformatics and related techniques to design the core regions of molecular functionality and to enable the generation, design, development and validation of peptide and small molecule ligands for existing and novel targets; prediction and design of peptides from DNA sequence data; data-mining operations; scientific research, namely, identification of targets for therapeutic applications and design of chemical inhibitors, agonists and antagonists; design, optimization and development of chemical inhibitors, agonists and antagonists for specific targets for therapeutic applications; design, creation and provision of informatics based programs designed to monitor and research scientific databases and identify potential leads matched to accompany discovery portfolio; genetic research services, namely, obtaining and analyzing genetic or chemical information; gene sequencing; laboratory research and collaboration with academic research groups in the field of drug discovery and healthcare research; pharmaceutical and bio technical research, namely, collaboration with pharmaceutical and biotechnology companies; drug discovery and development programs; synthesis of peptides and small molecules |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, October 4, 2013 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, October 4, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, October 4, 2013 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, October 4, 2013 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Proteom Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Babraham CB2 4AT GB |
| Party Name | Proteom Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Babraham CB2 4AT GB |
| Party Name | Proteom Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Babraham CB2 4AT GB |
| Event Date | Event Description |
| Friday, October 4, 2013 | CANCELLED SEC. 8 (6-YR) |
| Thursday, January 29, 2009 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| Tuesday, January 6, 2009 | ASSIGNED TO PARALEGAL |
| Thursday, November 20, 2008 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, February 27, 2007 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, January 11, 2007 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Monday, December 18, 2006 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, December 18, 2006 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, June 20, 2006 | EXTENSION 1 GRANTED |
| Tuesday, June 20, 2006 | EXTENSION 1 FILED |
| Tuesday, June 20, 2006 | TEAS EXTENSION RECEIVED |
| Wednesday, June 21, 2006 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Tuesday, June 20, 2006 | FAX RECEIVED |
| Tuesday, December 20, 2005 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 27, 2005 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Tuesday, September 27, 2005 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 7, 2005 | NOTICE OF PUBLICATION |
| Thursday, June 30, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, June 20, 2005 | ASSIGNED TO LIE |
| Wednesday, June 15, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 14, 2005 | AMENDMENT FROM APPLICANT ENTERED |
| Thursday, May 26, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 26, 2005 | PAPER RECEIVED |
| Monday, November 22, 2004 | NON-FINAL ACTION E-MAILED |
| Monday, November 22, 2004 | NON-FINAL ACTION WRITTEN |
| Friday, May 28, 2004 | FAX RECEIVED |
| Friday, May 28, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, May 1, 2004 | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Monday, September 29, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 30, 2003 | CASE FILE IN TICRS |
| Monday, September 29, 2003 | PAPER RECEIVED |
| Tuesday, March 25, 2003 | NON-FINAL ACTION E-MAILED |
| Monday, March 24, 2003 | ASSIGNED TO EXAMINER |
| Thursday, October 31, 2002 | PAPER RECEIVED |